Liabilities / Assets
24th percentile
Higher debt load relative to assets than 24% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
25th percentile
Higher debt load relative to revenue than 25% of similar nonprofits.
Net Margin
68th percentile
Higher net margin than 68% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
63rd percentile
Faster asset growth than 63% of similar nonprofits.
Revenue Growth
9th percentile
Faster revenue growth than 9% of similar nonprofits.
Balance Sheet
Assets
Up$1,143,713
Up $81,593 (+7.7%) from 2021
Net Assets
Up$1,139,745
Up $78,275 (+7.4%) from 2021
Liabilities
Up$3,968
Up $3,318 (+510%) from 2021
Revenue And Expenses
Revenue
Down$441,972
Down $316,357 (-42%) from 2021
Expenses
Up$363,697
Up $149,961 (+70%) from 2021
Net Income
Down$78,275
Down $466,318 (-86%) from 2021
Historical Trend
Filing Detail Status
This 2022 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2022 to Dec 31, 2022
Mission and Program Overview
Mission
Research and development with goal of defining a microvascular index for non-invasive monitoring of vascular health and for early diagnosis of vascular related diseases.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2022 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $1,143,713
- Liabilities
- $3,968
- Net assets
- $1,139,745
- Revenue
- $441,972
- Expenses
- $363,697
- Net income
- $78,275